Coronado Biosciences Signs Collaboration Agreement With Dr. Falk Pharma GmbH and OvaMed for the Development of TSO for Crohn's Disease
3/22/2012 7:34:47 AM
More...
|
Lipid Therapeutics Licenses European Rights to its Lead Product, LT-02, to Co-development Partner Dr. Falk Pharma GmbH
3/8/2012 10:40:53 AM
More...
|
Dong-A PharmTech and Dr. Falk Pharma GmbH Announce Positive Data in Portal Hypertension With Udenafil
6/13/2011 9:23:46 AM
More...
|
Cosmo Pharmaceuticals S.p.A. Announces Licensing Agreement with Dr. Falk Pharma GmbH for Rifamycin SV MMX(R)
11/24/2008 12:39:00 PM
More...
|
Sigma-Tau Pharmaceuticals Seeking FDA Approval of Medicine for Rare Genetic Disease Affecting Less Than 100 Americans
7/9/2008 12:37:08 PM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Acquires Budesonide Products from Dr. Falk Pharma GmbH
3/13/2008 9:47:48 AM
More...
|
Salix Pharmaceuticals, Ltd. (SLXP) Licenses DIACOL(TM) to Dr. Falk Pharma GmbH in Europe
4/17/2007 12:13:05 PM
More...
|
Altus Pharmaceuticals Inc. And Dr. Falk Pharma GmbH Announce TheraCLEC Granted Orphan Drug Designation By The European Medicines Evaluation Agency
10/19/2005 5:11:48 PM
More...
|